Unravel Biosciences, Inc. funding

Unravel Biosciences, Inc., a biotechnology company based in Medford, MA, filed a Form D with the SEC on August 24, 2026 and reported $4.1M raised of a $4.5M offering.

Amount raised$4.1M

Offering size$4.5M

Filed with the SECAugust 24, 2026

First saleAugust 7, 2026

IndustryBiotechnology

SecuritiesDebt, Options or warrants

LocationMedford, MA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far2

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 24

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care